(Q36275814)

13 August 2017

Erythropoietin Stimulates Tumor Growth via EphB4. (English)

1 reference

13 August 2017

1 reference

24

John E Ladbury

0 references

Kshipra Gharpure

Kshipra Gharpure

14

0 references

Archana S. Nagaraja

Archana S Nagaraja

16

0 references

Rajesha Rupaimoole

Rajesha Rupaimoole

Cristian Rodriguez-Aguayo

9

0 references

Cristian Rodriguez-Aguayo

34

0 references

Koji Matsuo

Koji Matsuo

29

0 references

Masato Nishimura

27

Masato Nishimura

1 reference

13 August 2017

39

Mien-Chie Hung

1 reference

13 August 2017

46

Anil K Sood

1 reference

13 August 2017

23

Loren J Stagg

1 reference

13 August 2017

Gabriel Lopez-Berestein

44

Gabriel Lopez-Berestein

1 reference

13 August 2017

Sunila Pradeep

1

1 reference

13 August 2017

Jie Huang

2

1 reference

13 August 2017

Edna M Mora

3

1 reference

13 August 2017

Alpa M Nick

4

1 reference

13 August 2017

Min Soon Cho

5

1 reference

13 August 2017

Sherry Y Wu

6

1 reference

13 August 2017

Kyunghee Noh

7

1 reference

13 August 2017

Chad V Pecot

8

1 reference

13 August 2017

Martin A Stein

10

1 reference

13 August 2017

Stephan Brock

11

1 reference

13 August 2017

Yunfei Wen

12

1 reference

13 August 2017

Chiyi Xiong

13

1 reference

13 August 2017

Jean M Hansen

15

1 reference

13 August 2017

Rebecca A Previs

17

1 reference

13 August 2017

Pablo Vivas-Mejia

18

1 reference

13 August 2017

Hee Dong Han

19

1 reference

13 August 2017

Wei Hu

20

1 reference

13 August 2017

Lingegowda S Mangala

21

1 reference

13 August 2017

Behrouz Zand

22

1 reference

13 August 2017

Bulent Ozpolat

25

1 reference

13 August 2017

S Neslihan Alpay

26

1 reference

13 August 2017

Rebecca L Stone

28

1 reference

13 August 2017

Guillermo N Armaiz-Peña

30

1 reference

13 August 2017

Heather J Dalton

31

1 reference

13 August 2017

Christopher Danes

32

1 reference

13 August 2017

Blake Goodman

33

1 reference

13 August 2017

Carola Kruger

35

1 reference

13 August 2017

Armin Schneider

36

1 reference

13 August 2017

Shyon Haghpeykar

37

1 reference

13 August 2017

Padmavathi Jaladurgam

38

1 reference

13 August 2017

Robert L Coleman

40

1 reference

13 August 2017

Jinsong Liu

41

1 reference

13 August 2017

Chun Li

42

1 reference

13 August 2017

Diana Urbauer

43

1 reference

13 August 2017

David B Jackson

45

1 reference

13 August 2017

14 October 2015

1 reference

13 August 2017

1 reference

13 August 2017

28

1 reference

13 August 2017

5

1 reference

13 August 2017

610-622

1 reference

Proteomics. Tissue-based map of the human proteome

13 August 2017

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

30 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

5 December 2018

https://pubmed.ncbi.nlm.nih.gov/26481148

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Hematogenous metastasis of ovarian cancer: rethinking mode of spread

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

The receptor that tames the innate immune response

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Nonerythropoietic properties of erythropoietin: implication for tissue protection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Erythropoietin receptor contributes to melanoma cell survival in vivo.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Molecular interaction studies using microscale thermophoresis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Erythropoietin, erythropoiesis and beyond

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Erythropoietin for oncology supportive care

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Role of erythropoeitin in prevention of chemotherapy-induced peripheral neuropathy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Use of erythropoietin-stimulating agents in breast cancer patients: a risk review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Dicer, Drosha, and outcomes in patients with ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Erythropoietin in cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Erythropoietin in cancer: an update.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Erythropoietin: physiology and molecular mechanisms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Does erythropoietin have a dark side? Epo signaling and cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Role of erythropoietin in the brain

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Efficiency of signalling through cytokine receptors depends critically on receptor orientation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Interleukin-3 (IL-3) inhibits erythropoietin-induced differentiation in Ba/F3 cells via the IL-3 receptor alpha subunit

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Identification of distinct receptor complexes that account for high-and low-affinity glucagon binding to hepatic plasma membranes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Hematology: ESAs to treat anemia--balancing the risks and benefits

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Erythropoietin improves functional and histological outcome in neonatal stroke

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Derivatives of erythropoietin that are tissue protective but not erythropoietic

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4643364

Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26481148

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CCELL.2015.09.008

1 reference

13 August 2017

1 reference

13 August 2017

1 reference